Fair Value Calculator Fair Value Calculator
EN DE

Sectra AB (SECT-B) Fair Value & Analysis

Healthcare · SE · Market cap 53.0B SEK

SA Sectra AB SECT-B · ST
Pricekr 272.40
Fair Valuekr 66.81
Upside-75.5%
Quality64/100
Watch Sectra AB for free, get notified when fair value or trend changes. Watch for free
Evidence: High Range kr 51.81 – kr 81.10 📤 Share as image

Fair value as of: Jul 17, 2026

From 24 valuation models · updated 4 days ago

Share price −1.6% over the past month.

Price vs Fair Value (12 months)

kr 370.75 kr 176.20 Fair Value kr 66.81 Jul 2025 Jul 2026

12‑month range kr 176.20 – kr 370.75 · fair‑value band kr 51.81 – kr 81.10 · the kr 272.40 price screens above the kr 66.81 fair value. As of Jul 17, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

Sectra AB (SECT-B) currently trades at kr 272.40, while our model-based Fair Value estimate is kr 66.81, implying the stock looks roughly 75.5% overvalued today. We read business quality at 64/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Sectra AB generated revenue of 3.6B SEK at a net margin of 15.5%. Revenue grew 13.0% year over year. It earns a return on equity of 27.8%. The balance sheet holds a net cash position of 1.7B SEK. Fundamentals as of Jul 17, 2026

Our scenario range runs from kr 51.81 (bear case) to kr 81.10 (bull case); at kr 272.40, the current price sits above that range. The share trades about 28% below its 52-week high and 57% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -39% fair-value upside, at -75%, SECT-B screens richer than that median.

Key figures & financial health

Revenue (TTM) 3.6B SEK
Revenue growth (YoY) +13.1%
Net margin 15.5%
Return on equity 27.8%
Free cash flow 1.0B SEK FY2026
P/E ratio 93.9
More key figures
Operating margin 18.6%
EPS (TTM) kr 2.93
Dividend yield 0.5%
EPS growth (YoY) +20.0%
Net cash 1.7B SEK FY2026

Figures from reported company fundamentals (EODHD) · as of Jul 17, 2026. TTM = trailing twelve months.

About the company

Sectra AB (publ) provides solutions for medical IT and cybersecurity sectors in Sweden, the United Kingdom, the Netherlands, and rest of Europe. The company operates through Imaging IT Solutions, Secure Communications, and Business Innovation segments. The Imaging IT Solutions segment develops and sells medical IT systems and services for managing, archiving, and presenting various types of medical images and patient information, as well as for operational follow-up and radiation dose monitoring; and maintenance and consulting services. The Secure Communications segment develops and sells products and services for secure voice and data communications, and project-based development, as well as security and threat analyses, and system monitoring services for control systems. The Business Innovation segment develops and sells IT systems for planning and monitoring orthopedic surgery; products for medical education and research projects; and IT support services for precision …

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

Sectra AB reported revenue of kr 3.5B in FY2026 versus kr 1.9B in FY2022, a compound +16.1%/yr. Reported net income was kr 564M in FY2026, compounding +15.7%/yr from FY2022.

Revenue +16.1%/yr
FY22 kr 1.9B
FY23 kr 2.4B
FY24 kr 3.0B
FY25 kr 3.2B
FY26 kr 3.5B
Net income +15.7%/yr
FY22 kr 315M
FY23 kr 375M
FY24 kr 428M
FY25 kr 563M
FY26 kr 564M

Is SECT-B fairly valued? → Check now

📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog, it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "Sectra AB Fair Value". https://www.fairvalue-calculator.com/stock/SECT-B

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection, not financial advice.

Similar stocks

10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jul 17, 2026).

Stock Price Fair Value vs Fair Value
Abbott Laboratories, ABT $87.83 $78.63 -10%
Stryker Corporation SYK $304.69 $186.28 -39%
Medtronic plc MDTC34 R$203.91 R$27.47 -87%
Boston Scientific Corporation B1SX34 R$229.30 R$43.33 -81%
Edwards Lifesciences Corporation EWL €75.46 €37.29 -51%
Siemens Healthineers AG SEMHF $39.91 $48.29 +21%
DexCom, Inc DXCM $72.59 $39.33 -46%
GE HealthCare Technologies Inc GEHC $60.64 $65.03 +7%
Shenzhen Mindray Bio-Medical Electronics Co 300760 ¥141.85 ¥147.63 +4%
Koninklijke Philips N.V PHG $26.98 $12.54 -54%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is Sectra AB (SECT-B) undervalued?
As of Jul 17, 2026, our model estimates a fair value of kr 66.81 versus a price of kr 272.40, about −75% (overvalued). Model-based estimate, not financial advice.
What is the fair value of SECT-B?
Our model-based fair value for Sectra AB is kr 66.81 (as of Jul 17, 2026), built from audited fundamentals. The current price is kr 272.40.
What is the quality score of SECT-B?
Sectra AB has a Quality Score of 64/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of Sectra AB (SECT-B)?
Sectra AB reported trailing-twelve-month revenue of about 3.6B SEK (latest available figure, as of Jul 17, 2026).
What is the net profit margin of SECT-B?
The net profit margin of Sectra AB is about 15.5%, meaning it keeps roughly 15.5% of revenue as net income. Based on the latest reported figures.
Does Sectra AB pay a dividend?
Sectra AB currently shows a dividend yield of about 0.44% relative to its recent price (as of Jul 17, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Unlock the full Sectra AB analysis, and try Pro free

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.